G. Lonnemann

G. Lonnemann, K. Koch, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Should ultra-pure dialysate be mandatory?

G. Lonnemann, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts.

C. Dinarello, G. Lonnemann, G. Müller, 1995, Kidney international.

Induction of tumor necrosis factor during extracorporeal blood purification.

C. Dinarello, J. V. D. van der Meer, J. Cannon, 1987, The New England journal of medicine.

Hemodialysis-associated induction of cytokines.

M. Haubitz, G. Lonnemann, R. Schindler, 1990, Blood purification.

Regulation of TNF-alpha, IL-1 and IL-6 synthesis in differentiating human monoblastoid leukemic U937 cells.

A. Hartmann, D. Männel, K. Resch, 1991, Leukemia research.

In vitro production of IL 1β, IL 1α, TNF and IL 2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation

J. Meer, C. Dinarello, J. Cannon, 1989 .

Interleukin-1 beta in human plasma: optimization of blood collection, plasma extraction, and radioimmunoassay methods.

J. Meer, C. Dinarello, J. V. D. van der Meer, 1988, Lymphokine research.

Concentrations of Immunoreactive Human Tumor Necrosis Factor Alpha Produced by Human Mononuclear Cells In Vitro

J. Meer, T. Ikejima, C. Dinarello, 1988, Journal of leukocyte biology.

Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement.

C. Dinarello, G. Lonnemann, R. Schindler, 1990, Kidney international.

Differences in the synthesis and kinetics of release of interleukin 1α, interleukin 1β and tumor necrosis factor from human mononuclear cells

J. Meer, C. Dinarello, J. Cannon, 1989, European journal of immunology.

Removal of Circulating Cytokines by Hemodialysis Membranes In Vitro

C. Dinarello, G. Lonnemann, R. Schindler, 1993 .

Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro.

P. Libby, T. Ikejima, C. Dinarello, 1987, Journal of immunology.

A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses.

L. Shapiro, C. Dinarello, S. Wolff, 1995, Journal of immunology.

The interleukin hypothesis

G. Lonnemann, K. Koch, S. Shaldon, 1988 .

Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1.

C. Dinarello, G. Lonnemann, K. Koch, 1988, The Journal of laboratory and clinical medicine.

Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor.

J. Meer, C. Dinarello, J. V. D. van der Meer, 1988, Clinical immunology and immunopathology.

Development and use of a radioimmunoassay for human interleukin-1 beta.

C. Dinarello, S. Endres, G. Lonnemann, 1987, Lymphokine research.

Chronic Inflammation in Hemodialysis: The Role of Contaminated Dialysate

G. Lonnemann, 2000, Blood Purification.

Permeability of dialyzer membranes to TNFα-inducing substances derived from water bacteria

G. Lonnemann, K. Koch, M. Schulze, 1992 .

A Phase I Study of Interleukin-10 in Healthy Humans: Safety and Effects on Cytokine Production

L. Shapiro, C. Dinarello, S. Wolff, 1995 .

Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients

Jens Gruber, G. Lonnemann, U. Rothbauer, 2022, Frontiers in Immunology.

Plasma C-reactive protein is linked to backfiltration associated interleukin-6 production.

C. Tetta, G. Lonnemann, V. Panichi, 1998, ASAIO journal.

New indicators to evaluate bacteriological quality of the dialysis fluid and the associated inflammatory response in ESRD patients.

G. Lonnemann, R. Schindler, K. Koch, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Are Standards for Dialysate Purity in Hemodialysis Insufficiently Strict?

G. Lonnemann, 2001, Seminars in dialysis.

Beta(2)-microglobulin amyloidosis: effects of ultrapure dialysate and type of dialyzer membrane.

G. Lonnemann, K. Koch, 2002, Journal of the American Society of Nephrology : JASN.

Low dialysance of asymmetric dimethylarginine (ADMA)--in vivo and in vitro evidence of significant protein binding.

D. Fliser, G. Lonnemann, S. Bode-Böger, 2004, Clinical nephrology.

Low-flux hemodialysis suppresses interferon-gamma production: the possible role of beta2-microglobulin.

C. Dinarello, F. Bahlmann, G. Lonnemann, 2009, Clinical nephrology.

Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood.

M. N. Marra, G. Lonnemann, V. Lufft, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

G. Lonnemann, E. Wrenger, 2011, Clinical nephrology.

Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients.

S. Dörge, P. Roux‐Lombard, J. Dayer, 1994, Transplantation.

Interleukin-18, interleukin-18 binding protein and impaired production of interferon-gamma in chronic renal failure.

C. Dinarello, G. Lonnemann, D. Novick, 2003, Clinical nephrology.

Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system.

J. Floege, G. Lonnemann, R. Brunkhorst, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Replacement of renal function by dialysis

G. Lonnemann, K. Koch, Gerhard Lonnemann, 1979 .

Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis.

J. Floege, C. Dinarello, G. Lonnemann, 1988, Kidney international.

Interleukin 18 and Interleukin 18 Binding Protein: Possible Role in Immunosuppression of Chronic Renal Failure

C. Dinarello, G. Lonnemann, D. Novick, 2003, Blood Purification.

A pilot study of coupled plasma filtration with adsorption in septic shock*

Rinaldo Bellomo, Claudio Ronco, Ciro Tetta, 2002, Critical care medicine.

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.

P. Weber, M. Klempner, E. Schaefer, 1989, The New England journal of medicine.

Letter to the editor response

G. Lonnemann, 2017 .

The Author Replies

G. Lonnemann, 2017, Kidney international reports.

Adherence to the Kidney Disease: Improving Global Outcomes CKD Guideline in Nephrology Practice Across Countries

C. Jacquelinet, M. Jadoul, W. Winkelmayer, 2020, Kidney international reports.

Ultrafiltration to reject human interleukin-1-inducing substances derived from bacterial cultures

C. Dinarello, G. Lonnemann, S. Shaldon, 1987, Journal of clinical microbiology.

A radioimmunoassay for human interleukin-1a: measurement of IL-1a produced in vitro by human blood mononuclear cells stimulated with endotoxin

J. Meer, C. Dinarello, J. Cannon, 1988 .

Long-term effects of vitamin E-bonded dialysis membrane on mononuclear cell activation, malondialdehyde generation and endothelial function in ESRD patients.

J. Bahlmann, G. Lonnemann, W. Gwinner, 1999, Contributions to nephrology.

Implementation and first results of a German chronic kidney disease registry.

D. Fliser, F. Port, R. Pisoni, 2013, Clinical nephrology.

Biological consequences of monocyte activation during hemodialysis.

C. Dinarello, G. Lonnemann, K. Koch, 1987, Contributions to nephrology.

ENHANCEMENT OF IN-VITRO HUMAN INTERLEUKIN-1 PRODUCTION BY SODIUM ACETATE

C. Dinarello, G. Lonnemann, K. Koch, 1987, The Lancet.

Plasma interleukin-1 activity during hemodialysis: the influence of dialysis membranes.

C. Dinarello, G. Lonnemann, K. Koch, 1988, Nephron.

Quality of water and dialysate in haemodialysis.

G. Lonnemann, K. Koch, S. Krautzig, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Complications Related to Water Treatment, Substitution Fluids and Dialysate Composition

J. Floege, G. Lonnemann, 2000 .

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis

Jens Gruber, G. Lonnemann, U. Rothbauer, 2021, EBioMedicine.

Pyrogen retention by highly permeable synthetic membranes during in vitro dialysis.

C. Tetta, G. Lonnemann, H. Lemke, 2001, Artificial organs.

Effects of dialyzer membrane on interleukin-1β (IL-1β) and IL-1β—converting enzyme in mononuclear cells

G. Lonnemann, S. Linnenweber, 2001 .

Effects of dialyzer membrane on interleukin-1beta (IL-1beta) and IL-1beta-converting enzyme in mononuclear cells.

G. Lonnemann, S. Linnenweber, 2001, Kidney international. Supplement.

Assessment of the quality of dialysate.

G. Lonnemann, G. Lonnemann, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria.

G. Lonnemann, K. Koch, M. Schulze, 1992, Kidney international.

The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes.

G. Lonnemann, V. Lufft, R. Schindler, 1995, Nephrology, Dialysis and Transplantation.

In vitro production of interleukin-1 from blood mononuclear cells of patients on chronic hemodialysis therapy.

M. Haubitz, G. Lonnemann, B. Klöppel, 1992, Clinical Nephrology.

Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption.

C. Ronco, J. Cavaillon, G. Camussi, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Impaired endotoxin-induced interleukin-1 beta secretion, not total production, of mononuclear cells from ESRD patients.

M. Haubitz, G. Lonnemann, R. Schindler, 1995, Kidney international.

Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate.

G. Lonnemann, R. Schindler, 1994, Clinical nephrology.

Pyrogen Retention by the Asahi APS-650 Polysulfone Dialyzer during In Vitro Dialysis with Whole Human Donor Blood

G. Lonnemann, S. Linnenweber, Silvia Linnenweber, 2000, ASAIO journal.

Reimbursement of dialysis: a comparison of seven countries.

Andrew Davenport, Wim Van Biesen, Raymond Vanholder, 2012, Journal of the American Society of Nephrology : JASN.

Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill.

R. Bellomo, C. Ronco, C. Tetta, 1999, Kidney international. Supplement.

CAPD is a second-class treatment.

C. Dinarello, G. Lonnemann, K. Koch, 1985, Contributions to nephrology.

A Switch to High-Flux Helixone® Membranes Reverses Suppressed Interferon-γ Production in Patients on Low-Flux Dialysis

C. Dinarello, G. Lonnemann, D. Lang, 2003, Blood Purification.

Minimal change nephrotic syndrome in a 74-year-old patient following parenteral administration of sheep cells.

J. Floege, G. Lonnemann, R. Brunkhorst, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Associations of Hemoglobin Levels With Health-Related Quality of Life, Physical Activity, and Clinical Outcomes in Persons With Stage 3-5 Nondialysis CKD.

C. Jacquelinet, D. Fliser, Z. Massy, 2020, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Clinical, hematologic, and immunologic effects of interleukin-10 in humans

Edouard Vannier, L. Shapiro, C. Dinarello, 1996, Journal of Clinical Immunology.

Life-Threatening Complications of Extracorporeal Treatment in Patients with Severe Eosinophilia

F. Bahlmann, G. Lonnemann, W. Gwinner, 2005, The International journal of artificial organs.

Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study

D. Fliser, B. Stengel, R. Pisoni, 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination

G. Lonnemann, U. Rothbauer, P. Kaiser, 2021, medRxiv.

Impaired NK Cell Function in ESRD Patients

G. Lonnemann, 2008, Blood Purification.

International practice patterns of dyslipidemia management in patients with chronic kidney disease under nephrology care: is it time to review guideline recommendations?

C. Jacquelinet, D. Fliser, F. Port, 2023, Lipids in Health and Disease.

Differential modulation of synthesis of human IL-1 beta and IL-1 receptor antagonist by cyclosporin A.

G. Lonnemann, V. Lufft, S. Linneweber, 2002, Transplantation proceedings.

Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.

G. Lonnemann, K. Koch, M. Burg, 1999, Kidney international. Supplement.

G. Lonnemann, E. Wrenger, 2012 .

In vitro production of IL 1 beta, IL 1 alpha, TNF and IL2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation.

C. Dinarello, J. V. D. van der Meer, J. Cannon, 1989, European journal of immunology.

A radioimmunoassay for human interleukin-1 alpha: measurement of IL-1 alpha produced in vitro by human blood mononuclear cells stimulated with endotoxin.

C. Dinarello, J. V. D. van der Meer, J. Cannon, 1988, Lymphokine research.

Transfer of endogenous pyrogens across artificial membranes?

G. Lonnemann, K. Koch, M. Burg, 1998, Kidney international. Supplement.

Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood.

G. Lonnemann, V. Lufft, R. Schindler, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Potential Surrogate Outcomes for Kidney Failure in Advanced CKD: Evaluation of Power and Predictive Ability in CKDopps

C. Jacquelinet, D. Fliser, B. Stengel, 2021, Kidney medicine.

Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis.

M. Oppermann, G. Lonnemann, R. Schindler, 1993, Clinical nephrology.